FLT3 and acute myeloid leukemia: Fms-like tyrosine kinase-3 gene (FLT3) and nucleophosmin-1 (NPM1) mutations are the most frequent acquired molecular abnormalities in cytogenetically normal (CN) AML (Falini et al., 2005; Renneville et al., 2008).